APOP

Cellect Biotechnology (APOP)

Cellect Biotechnology Ltd

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:APOP

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
06/28/2023	3:04PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd
06/28/2023	3:02PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:APOP	Cellect Biotechnology Ltd
05/12/2023	4:34PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:APOP	Cellect Biotechnology Ltd
05/09/2023	4:03PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd
05/09/2023	3:04PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:APOP	Cellect Biotechnology Ltd
05/08/2023	5:15PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:APOP	Cellect Biotechnology Ltd
03/22/2023	6:02AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd
03/20/2023	6:06AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:APOP	Cellect Biotechnology Ltd
03/15/2023	2:40PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:APOP	Cellect Biotechnology Ltd
03/03/2023	4:20PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:APOP	Cellect Biotechnology Ltd
02/28/2023	6:14AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd
02/28/2023	6:14AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd
02/28/2023	6:13AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd
02/23/2023	6:05AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:APOP	Cellect Biotechnology Ltd
02/14/2023	2:41PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:APOP	Cellect Biotechnology Ltd
02/14/2023	11:26AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:APOP	Cellect Biotechnology Ltd
02/13/2023	6:10AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:APOP	Cellect Biotechnology Ltd
02/09/2023	6:05AM	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:APOP	Cellect Biotechnology Ltd
02/03/2023	6:03AM	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:APOP	Cellect Biotechnology Ltd
01/03/2023	9:48AM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:APOP	Cellect Biotechnology Ltd
01/03/2023	9:45AM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:APOP	Cellect Biotechnology Ltd
01/03/2023	9:44AM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:APOP	Cellect Biotechnology Ltd
01/03/2023	9:41AM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:APOP	Cellect Biotechnology Ltd
01/03/2023	9:38AM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:APOP	Cellect Biotechnology Ltd
11/10/2022	12:45PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd
11/10/2022	12:44PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd
11/10/2022	11:09AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:APOP	Cellect Biotechnology Ltd
11/07/2022	2:46PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd
11/07/2022	2:45PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:APOP	Cellect Biotechnology Ltd
10/28/2022	6:06AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:APOP	Cellect Biotechnology Ltd